Diamond Therapeutics

Diamond Therapeutics is a Toronto-based psychedelic drug development company. Our mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. Diamond focuses on sub-perceptual, non-hallucinogenic treatments that have the potential for use across a wide patient population – maximizing the positive impact that better medicines can have on the global mental health crisis.